Abstract:Purpose: From a diagnostic standpoint, certain approaches to genetic screening in clinical practice remain ambiguous in the era of assisted reproduction. Even the most current guidelines do not provide definite guidance on testing protocols, leaving clinicians to carefully determine which tests best serve patients struggling with infertility. The lack of uniformity in the current practice of male fertility evaluation can prove to be quite costly, thus necessitating healthcare practitioners to carefully appraise the necessity and weigh the advantages against potential economic and psychological detriments. The objective of this review is to map the existing literature on the general topic of the clinical indications of routine karyotyping and/or AZF screening in infertile men, identify key concepts, determine where the gaps are, and lastly, provide an overview of the conclusions drawn from a body of knowledge that varies widely in terms of methodologies or disciplines. Materials and methods: A thorough search was conducted for the published findings up until July 2023, utilizing PubMed (MEDLINE). This comprehensive search involved the use of specific search keywords, either individually or in combination. The search terms employed were as follows: "Karyotype", "Klinefelter" or "KS" or "47,XXY", "AZF" or "Azoospermi*" and/or "microdeletion*" in the title or abstract. Once the titles and abstracts of selected articles were obtained, the complete texts of linked papers were meticulously scrutinized. Results: A total of 191 records were identified from PubMed. During screening, 161 records (84.3%) were eliminated. Finally, 30 papers were included in this scoping review, which was conducted in 18 countries. The number of sequence tag sites (STSs) used in the studies varied from 5 to 59. The rate of AZF deletions among patients with NOA ranged from 1.3% to 53%. The mean frequency was estimated to be 5.6%. The rate of YCM among patients with XXY karyotype was nil in 19 out of 30 studies (63%), whilst, in the remaining studies, the rate varied from 0.8% to 67%. Conclusion: This review provides insights into managing male infertility. The presence of spermatozoa in ejaculation and successful surgical retrieval cannot be excluded for individuals with AZFb/AZFbc microdeletions. Screening for Y chromosome microdeletions is not needed for mosaic or classic KS. Only 1% of individuals with sperm concentration exceeding 1×106 sperm/mL and less than 5×106 sperm/mL exhibit AZF microdeletions; therefore, testing referral for such populations may need reassessment. Individuals with mosaic monosomy X karyotype and certain chromosomal anomalies should be referred for AZF deletion screening. These findings have implications for male infertility management and future research.

Chromosomal studies in infertile men with oligozoospermia & non-obstructive azoospermia

A retrospective analysis of 1600 infertility patients with azoospermia and severe oligozoospermia

Clinical Review#: State of the art for genetic testing of infertile men

Cytogenetic analysis in 609 cases of men with azoospermia or oligozoospermia

Cytogenetic and molecular study of 370 infertile men in South India highlighting the importance of copy number variations by multiplex ligation-dependent probe amplification

The clinical significance analysis of the cytogentic abnormality in the infertile males

The association between the two more common genetic causes of spermatogenic failure: a 7-year retrospective study

Chromosomal Abnormalities with Male Infertility

Molecular screening for Yq microdeletion in men with idiopathic oligozoospermia and azoospermia

Genetic screening of karyotypes and azoospermic factors for infertile men who are candidates for ICSI

Cytogenetic and molecular genetic analysis of 424 cases with non-obstructive azoospermia or severe oligospernia

Multicenter Study Of Genetic Abnormalities Associated With Severe Oligospermia And Non-Obstructive Azoospermia

Chromosomal Abnormality and Y Chromosome Microdeletion in Chinese Patients with Azoospermia or Severe Oligozoo-spermia

AZF microdeletions associated with idiopathic and non-idiopathic cases with cryptorchidism and varicocele

The Role of Male Chromosomal Polymorphism Played in Spermatogenesis and the Outcome of IVF/ICSI-ET Treatment.

New Insights beyond Established Norms: A Scoping Review of Genetic Testing for Infertile Men

Complex Y chromosome anomalies in an infertile male

Y choromosomal microdeletion screening in the workup of male infertility and its current status in India

Chromosome abnormalities in sperm from infertile men with normal somatic karyotypes: teratozoospermia

Chromosomal and Y-chromosome microdeletion analysis in 1,300 infertile males and the fertility outcome of patients with AZFc microdeletions

Clinical, cytogenomic, and molecular characterization of isodicentric Y-chromosome and prediction of testicular sperm retrieval outcomes in azoospermic and severe oligozoospermic infertile men